Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

CVS Health Corp (NY:CVS)

93.02 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EDT, Aug 21, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about CVS Health Corp

< Previous 1 2
...
30 31 32 33 34 35 36 37 38
...
71 72 Next >
News headline image
3 Healthcare Stocks to Sell in May Before They Crash & Burn ↗
With the stock market uncertain and rising theft, these are three healthcare stocks to sell in the event of a market downturn. 
Via InvestorPlace
News headline image
NVIDIA To Rally More Than 19%? Here Are 10 Top Analyst Forecasts For Tuesday ↗
 
Via Benzinga
News headline image
The 7 Most Undervalued Stocks to Buy Now: Q2 Edition ↗
These undervalued stocks have the potential to deliver substantial returns as they rebound toward their intrinsic values. 
Via InvestorPlace
News headline image
3 Insurance Stocks That Could Make You a Millionaire ↗
The insurance business can be a great way to build wealth over time. 
Via The Motley Fool
News headline image
Last Week's Worst-Performing Stocks: Are These 15 Large-Cap Stocks In Your Portfolio? (April 28-May 4, 2024) ↗
15 large-cap stocks had a rough week, with CVS, Starbucks, and DoorDash all taking major hits. Analysts have lowered price targets on many. 
Via Benzinga
News headline image
CVS Health Unusual Options Activity ↗
 
Via Benzinga
News headline image
Expert Outlook: CVS Health Through The Eyes Of 11 Analysts ↗
 
Via Benzinga
News headline image
3 High-Yield Dividend Stocks to Buy Now and Hold at Least a Decade ↗
These highly advantaged businesses have what they need to keep raising their dividend payouts. 
Via The Motley Fool
News headline image
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of CVS Health Corporation (CVS) on Behalf of Investors
From Glancy Prongay & Murray LLP
Via Business Wire
News headline image
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of CVS Health Corporation (CVS) on Behalf of Investors
From Law Offices of Howard G. Smith
Via Business Wire
News headline image
The Law Offices of Frank R. Cruz Announces Investigation of CVS Health Corporation (CVS) on Behalf of Investors
From The Law Offices of Frank R. Cruz
Via Business Wire
News headline image
CVS Is Sick ↗
One would figure the nation’s biggest pharmacy would be a safe, conservative investment. Nope. CVS​​​​​​​ has lost about HALF its value in just two years. 
Via Talk Markets
News headline image
Why CVS Health Stock Plunged Today ↗
Its profits took a hit as its insurance benefit payouts rose. 
Via The Motley Fool
News headline image
10 Health Care Stocks Whale Activity In Today's Session ↗
 
Via Benzinga
News headline image
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against CVS Health Corporation and Encourages Investors to Contact the Firm
From Schall Law
Via GlobeNewswire
News headline image
CVS Health (CVS) Q1 2024 Earnings Call Transcript ↗
CVS earnings call for the period ending March 31, 2024. 
Via The Motley Fool
Topics Earnings
News headline image
Moody’s, Booking, DraftKings, Amgen Stocks In Focus Ahead Of Earnings ↗
American stocks were mixed on Wednesday as the earnings season continued and as investors waited for the latest Federal Reserve decision. The Dow Jones rose by over 65 points while the S&P 500 and... 
Via Talk Markets
Topics Economy Stocks
News headline image
Unpacking the Latest Options Trading Trends in CVS Health ↗
 
Via Benzinga
News headline image
Why AMD Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
 
Via Benzinga
News headline image
CVS Shares Dump On Earnings Miss, Outlook Slashed On Rising Medical Costs ↗
CVS shares plunged after first-quarter revenue and adjusted earnings missed Wall Street's average expectations. The drugstore chain also slashed its full-year profit outlook, citing rising medical... 
Via Talk Markets
Topics Earnings
News headline image
CVS Stock Earnings: CVS Health Misses EPS, Misses Revenue for Q1 2024 ↗
CVS stock results show that CVS Health missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024. 
Via InvestorPlace
News headline image
Rising Cost For Health Insurers Bites CVS Health's Q1 Profit, Stock Tanks ↗
CVS Health Q1 sales of $88.4 billion, up 3.7% Y/Y. Adjusted EPS at $1.31, down from $2.20. Health Care Benefits segment sees strong growth, while Health Services segment faces challenges. Revised 2024... 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
CVS Health Dives To 3-Year Low On Medicare Cost Surge ↗
CVS earnings tumbled more than expected on a surge in Medicare costs. 
Via Investor's Business Daily
News headline image
Humana Leaves Shareholders in Limbo on 2025 EPS Guidance
Health insurer Humana reported Q1 2024 earnings, getting a less dramatic reaction than its Q4 2023 report, causing shares to tumble more than 13%. 
Via MarketBeat
News headline image
Wall Street Set To Open Lower After AMD Earnings Disappoint As Traders Look To Fed's Powell For Relief: Why This Analyst Sees Incoming Summer Rally ↗
A negative sentiment might linger on Wall Street on Wednesday, as evidenced by stock futures, after Advanced Micro Devices, Inc.‘s (NASDAQ:AMD) 
Via Benzinga
Topics Economy
News headline image
CVS Stock is Nearing a 52-Week Low, Better Buy Than Walgreens?
CVS stock is making its way above Walgreens as a potential watchlist addition. Fundamentals and price targets see the stock making a comeback this year. 
Via MarketBeat
News headline image
Walmart Pulls Plug On Health Centers, Telehealth; Respite For TDOC? ↗
Walmart is shutting down its health centers and virtual care offering, continuing a broader shakeup in telehealth. WMT stock is near a buy point. 
Via Investor's Business Daily
News headline image
AbbVie Outlook: Why Humira Biosimilars Won't Undo A Projected $73 Billion In Sales ↗
The company is projected to bring in increasing sales through at least 2029. 
Via Investor's Business Daily
< Previous 1 2
...
30 31 32 33 34 35 36 37 38
...
71 72 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.